GWM
BLFS icon

Gilpin Wealth Management’s BioLife Solutions BLFS Stock Holding History

Gilpin Wealth Management’s Portfolio BLFS Stock Details BLFS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$311 Sell
11
-12
-52% -$280 ﹤0.01% 815
2026
Q1 		$439 Buy
23
+20
+667% +$442 ﹤0.01% 653
2025
Q4 		$73 Buy
+3
New +$78 ﹤0.01% 889

Other funds holding BLFS

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Gilpin Wealth Management's BLFS Position: Q2 2026 in Review

Gilpin Wealth Management reduced its BioLife Solutions (BLFS) stake by 52% in Q2 2026, selling an estimated $280 and leaving 11 shares worth $311. The position accounts for ﹤0.01% of the portfolio, ranked #815.

Gilpin Wealth Management first reported a position in BLFS in Q4 2025 and has held it in 3 quarters since. The position peaked at $439 in Q1 2026. 216 funds tracked by Wall St. Rank hold BLFS as of Q2 2026.

  • Gilpin Wealth Management held 11 shares of BioLife Solutions worth $311 as of Q2 2026.
  • Gilpin Wealth Management sold 12 BioLife Solutions shares in Q2 2026, an estimated $280.
  • BioLife Solutions made up ﹤0.01% of Gilpin Wealth Management's portfolio in Q2 2026, its #815 holding.
  • Gilpin Wealth Management first reported a position in BioLife Solutions in Q4 2025 and has held it in 3 quarters since.
  • Gilpin Wealth Management's BioLife Solutions position peaked at $439 in Q1 2026.
  • 216 funds tracked by Wall St. Rank held BioLife Solutions as of Q2 2026.

Based on Gilpin Wealth Management's 13F filing for Q2 2026, filed 24 Jul 2026.